ezogabine has been researched along with Genetic Predisposition in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bock, M; Danker, T; De Jonghe, P; Guenther, E; Ilina, EI; Jezutkovic, N; Lerche, H; Löffler, H; Maljevic, S; Mandelstam, S; Orhan, G; Reichel, SN; Scheffer, IE; Schepers, D; Suls, A; Weckhuysen, S | 1 |
Frankel, WN; Otto, JF; White, HS; Wilcox, KS; Yang, Y | 1 |
2 other study(ies) available for ezogabine and Genetic Predisposition
Article | Year |
---|---|
Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.
Topics: Animals; Carbamates; Epilepsy, Benign Neonatal; Genetic Predisposition to Disease; Humans; KCNQ2 Potassium Channel; Membrane Potentials; Mutation, Missense; Oocytes; Phenylenediamines; Potassium Channels, Voltage-Gated; Xenopus | 2014 |
Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
Topics: Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Electroshock; Female; Genetic Predisposition to Disease; Indoles; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Mutation; Nerve Tissue Proteins; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Receptors, Nicotinic; Seizures; Sequence Deletion | 2004 |